Extended-Duration Betrixaban Reduces the Risk of Venous Thromboembolism-Related Rehospitalization Among Acutely Ill Hospitalized Medical Patients: An APEX Trial Substudy

Francisco Daniel Epelde Gonzalo

Research output: Contribution to journal › Article › Research › peer-review

Cite this